N-(3-Acetylphenyl)-5-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)-2-methylthiophene-3-sulfonamide

Catalog No. :
ACVLYO433
CAS No. :
1223896-91-0
Molecular Formula :
C21H16ClN3O4S2
Molecular Weight :
473.96

IUPAC Name:N-(3-acetylphenyl)-5-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)-2-methylthiophene-3-sulfonamide

N-(3-Acetylphenyl)-5-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)-2-methylthiophene-3-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Acetylphenyl)-5-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)-2-methylthiophene-3-sulfonamide
IUPAC NameN-(3-acetylphenyl)-5-(3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl)-2-methylthiophene-3-sulfonamide
Molecular FormulaC21H16ClN3O4S2
Molecular Weight473.96
SMILESO=S(C1=C(C)SC(C2=NC(C3=CC=C(Cl)C=C3)=NO2)=C1)(NC4=CC=CC(C(C)=O)=C4)=O
InChI KeyMDIWFXUJPFTABG-UHFFFAOYSA-N
Synonym3-Thiophenesulfonamide, N-(3-acetylphenyl)-5-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]-2-methyl-
CAS No.1223896-91-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVLYO433 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRNS458 route compound structure diagram
    ACLRNS45899-03-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVLYO433 route product structure diagram
    ACVLYO4331223896-91-0
Inquiry

2. ACVLYO433 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVLYO433 route product structure diagram
    ACVLYO4331223896-91-0
Inquiry

Comments (0)